Drugs / Anaferon for Children
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03301155 | Oct 2017 → May 2019 | — | Materia Medica Holding | Completed | Met primary |
| Phase 4 | NCT02072174 | Oct 2014 → Apr 2018 | viral respiratory tract infection | Materia Medica Holding | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Anaferon for children | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03301155 ↗ |
| Route | Oral | “Anaferon for children: For oral use.” NCT02072174 ↗ |